格隆汇3月9日丨复星国际(00656.HK)发布公告，公司于2026年3月6日收到公司控股股东复星控股有限公 司("控股股东")及高级管理人员("高管")的通知，基于对集团的前景及增长潜力充满信心，以及对公司 长远投资价值的认可，控股股东及高管计划自公司2025年度业绩公告发布后的12个月内于公开市场交易 中增持本公司股份。 控股股东及高管对公司股份的任何买入均将严格遵守上市规则、所有适用法律及公司的内部控制及证券 交易政策。根据上市规则有关最低公众持股量的规定，为确保公司持续符合相关要求，控股股东及高管 本次拟增持公司股份的总金额不超过港币5亿元。 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性或完整性亦不發表任何聲明，並明確表示，概不 就 因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 控股股東及高 管 對 本 公 司 股 份 的 任 何 買 入 均 將 嚴 格 遵 守 香港聯合交易所有限公 司證 券 上市 規 則（「 上市規則 」）、所有 適用 法 律及 本 公司 的內 部 控制 及 證券 交易 政策。根 據上 市 規則 有關 最 低公 眾 持股 量的 規 定，為 確 保本 公司 持 續符 合 相關 要 求，控 股 股東 及 高 管本 次 擬增 持 本公 司股 份 的總 金 額不 超過 港 幣 5 億 元（「 本 次 增持計劃 」）。 本公司 股東及 潛 在 投資者應注意， 本 次 增 持 計 劃 存 在 因 資 本 市 場 發 生 變 化 或 目 前尚無法預判的其他因素導致無法或部分無法實施的風險 。 本公司 股 東 及 潛 在 投資者於買賣本 公司 證 券 時 務 請審 慎行 事 。 承董事會命 復星國 ...

Core Viewpoint - Fosun International expects a loss of approximately RMB 21.5 billion to RMB 23.5 billion for the fiscal year 2025 due to significant non-cash impairment charges and value reassessments of certain assets [2][3] Group 1: Financial Performance - The company reported a projected loss for 2025 primarily due to a continued downturn in the real estate sector and overall weak market demand, leading to substantial asset impairment provisions [2] - In 2024, Fosun International experienced a loss of RMB 4.35 billion, influenced by adjustments to the book value of investments and declining profits in its subsidiaries [3] - The company has faced significant declines in profitability in previous years, with a 94.77% drop in net profit in 2022 [3] Group 2: Strategic Adjustments - Fosun International's board believes that the large non-cash impairments are necessary to accurately reflect the company's financial status and do not affect overall operations and cash flow [3] - The company plans to dynamically adjust its operational and sales strategies based on market conditions, focusing on core businesses and financial health to enhance long-term value [3] - A new share buyback plan has been announced, with a total amount not exceeding HKD 1 billion, indicating confidence in the company's long-term prospects [5] Group 3: Market Reaction - The company's stock price has been on a downward trend, falling over 70% from its peak of HKD 12.48 in May 2021 to HKD 3.59 as of March 6 [4] - The timing of the asset impairment is viewed by the market as a proactive measure to shed historical burdens and position the company for better performance in 2026 [5]

Core Viewpoint - Fosun International (00656.HK) issued a profit warning, expecting a net loss of approximately 21.5 billion to 23.5 billion yuan for the fiscal year 2025, primarily due to one-time non-cash impairment charges related to real estate projects and some non-core business goodwill [1] Group 1: Net Asset Value (NAV) and Financial Health - As of December 31, 2024, Fosun International's net assets attributable to shareholders were 118.103 billion yuan. After accounting for the expected impairment of 22.5 billion yuan, the adjusted net assets would be approximately 95.603 billion yuan, maintaining a robust scale close to 100 billion yuan [2] - The impairment is mainly concentrated in the real estate sector and non-core business goodwill, reflecting a prudent adjustment in light of the real estate industry's downturn and Fosun's strategy to streamline and focus on core businesses [2] - The latest stock price of Fosun International indicates a significant discount of about 75% to the post-impairment net asset value, suggesting a notable margin of safety for investors [3] Group 2: Core Business Development and Market Signals - Fosun's core businesses, including pharmaceuticals, insurance finance, and cultural tourism, have shown strong growth momentum at the beginning of 2026 [4] - In the pharmaceutical sector, Fosun has opened substantial global market opportunities with agreements potentially exceeding 2 billion USD with Pfizer and up to 7.25 billion USD with Clavis Bio [4] - Fosun has also increased its share buyback efforts, planning to repurchase up to 1 billion HKD worth of shares, signaling confidence in the company's long-term prospects [5]

Core Viewpoint - Fosun International announced an expected loss of 21.5 billion to 23.5 billion yuan attributable to shareholders in 2025, primarily due to one-time non-cash impairment charges and value reassessments of certain assets, which will not affect the company's overall operations and cash flow [1] Group 1: Financial Performance - The significant loss is attributed to the real estate sector facing pressure, leading the company to prudently recognize large impairment provisions for projects showing signs of impairment [1] - Additionally, due to market changes, impairment provisions were made for goodwill and intangible assets in some non-core business segments to objectively reflect their value [1] Group 2: Market Confidence - Fosun International is increasing its share buyback efforts to convey confidence in the market, planning to repurchase shares for a total amount not exceeding 1 billion Hong Kong dollars from the announcement of the 2025 performance until the 2026 annual general meeting [1] - Prior to this announcement, the company had already repurchased 13.027 million shares for 48.2354 million Hong Kong dollars on February 27 [1]

Core Viewpoint - Fosun International (00656.HK) issued a profit warning, projecting a significant net loss of approximately 21.5 billion to 23.5 billion yuan for the fiscal year 2025, primarily due to one-time non-cash impairment charges and value reassessments [1] Group 1: Financial Performance - For the years 2021 to 2024, Fosun International reported revenues of 161.3 billion, 182.4 billion, 198.2 billion, and 192.1 billion yuan respectively, with net profits fluctuating significantly at 10.08 billion, -0.832 billion, 1.379 billion, and -4.349 billion yuan [2] - The company anticipates a large accounting loss for 2025 due to two main factors: ongoing downturn in the real estate sector leading to substantial asset impairment provisions, and impairment provisions for goodwill and intangible assets in non-core business segments [1] Group 2: Strategic Initiatives - On February 27, Fosun International announced a capital increase in Zhejiang Shangmeng Technology Co., Ltd. by investing 105 million yuan, acquiring a 51.0879% stake and becoming the largest shareholder [2] - The company aims to leverage the growth potential of Shangmeng Technology and enhance synergies with its online and offline ecosystem [2] Group 3: Market Confidence - To bolster market confidence, Fosun International is increasing its share buyback efforts, planning to repurchase shares worth up to 1 billion HKD from the announcement of the 2025 performance report until the 2026 annual general meeting [3] - As of March 6, the stock price of Fosun International closed at 3.59 HKD per share, reflecting a decline of 1.1% [4]

Group 1 - The core viewpoint of the announcement is that Fosun International expects a significant increase in net loss for the fiscal year 2025, estimated between 21.5 billion to 23.5 billion yuan, compared to a net loss of approximately 4.349 billion yuan in 2024 [1] - The primary reason for the substantial loss in the financial statements for 2025 is attributed to one-time non-cash impairment charges and value reassessments of certain assets, particularly in the real estate sector, which is under pressure due to a prolonged downturn and weak market demand [1] - The company plans to dynamically adjust its operational and sales strategies based on market conditions, enhance marketing efforts, and accelerate cash recovery [1] Group 2 - The board of directors believes that the large non-cash impairments and provisions are intended to accurately reflect the company's financial information and do not impact overall operations and cash flow [2] - The core industries of the company, such as pharmaceuticals and insurance, are showing good development trends, indicating a stable fundamental performance [2] - The company will continue to focus on its core business strategy and financial strategy aimed at promoting business growth and solidifying long-term value for shareholders [2] Group 3 - As of the close of trading, Fosun International's stock price was reported at 3.59 HKD per share, reflecting a decline of 1.1% [3]

钛媒体App 3月6日消息，复星国际在港交所发布公告称，2025财政年度归属于母公司股东之亏损预计约 为人民币215亿元至人民币235亿元。主要由于对部分存在减值迹象的地产项目以及部分非核心业务板块 的商誉、无形资产等计提了减值准备。董事会认为上述资产减值为非现金项目，不影响公司整体运营和 现金流。（公司公告） ...

复星国际在港交所发布公告称，2025财政年度归属于母公司股东之亏损预计约为人民币215亿元至人民 币235亿元。主要由于对部分存在减值迹象的地产项目以及部分非核心业务板块的商誉、无形资产等计 提了减值准备。董事会认为上述资产减值为非现金项目，不影响公司整体运营和现金流。 来源：滚动播报 ...

Core Viewpoint - Fosun International (00656) issued a profit warning, projecting a loss of approximately RMB 21.5 billion to RMB 23.5 billion for the fiscal year 2025, primarily due to one-time non-cash impairment charges and value reassessments, which do not affect overall operations and cash flow [1][2] Group 1: Financial Performance - The significant loss is attributed to the ongoing downturn in the real estate sector, leading to a soft market demand and pressure on the group's real estate business, prompting substantial asset impairment provisions [1] - The company plans to dynamically adjust its operational and sales strategies based on market conditions, aiming to enhance marketing efforts and accelerate cash recovery [1] - In the insurance sector, Fosun's Portuguese insurance reported a net profit of €170 million for the first three quarters of 2025, a year-on-year increase of 11.7%, while domestic insurance companies also reported considerable growth in premiums and net profits [3] Group 2: Strategic Focus - Fosun emphasizes its commitment to a "focus on core business" strategy and a "streamlining" financial strategy to promote business growth and solidify long-term value [1][3] - The company has engaged in significant partnerships in the innovative drug sector, including a global exclusive licensing agreement with Pfizer worth over $2 billion and a strategic collaboration with Clavis Bio potentially worth up to $7.25 billion [2] - The company is also increasing its share buyback efforts to instill market confidence, planning to repurchase shares up to HKD 1 billion following the 2025 annual performance announcement [4]